Amgen’s $400 million eczema drug candidate has recorded two more phase 3 victories. The data drops provide more evidence that ...
Starship, the most powerful launch system ever built, is set to take off on its eighth test flight about six weeks after an ...
In September 2024, a readout from a separate trial of rocatinlimab elicited mixed reactions from analysts, who found the ...
SpaceX has released footage of the most recent Starship launch from an angle I didn't think was possible, showcasing the ...
Results from IGNITE, SHUTTLE and VOYAGER will be presented at upcoming congresses or published in peer-reviewed journals. About the ROCKET Phase 3 Program ROCKET is a comprehensive, global Phase 3 ...
Amgen (AMGN) and Kyowa Kirin (KYKOF) announced new results from the ongoing ROCKET Phase 3 clinical trial program evaluating rocatinlimab, an ...
Amgen & Kyowa Kirin positive results from rocatinlimab phase 3 IGNITE study in adults with moderate to severe atopic dermatitis: Thousand Oaks, California Tuesday, March 11, 2025, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results